TYRA logo

Tyra Biosciences, Inc. Common Stock


TYRA: Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. Its lead product candidate is TYRA-300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).


Show TYRA Financials

Consumer Interest
SEC Filings

Recent trades of TYRA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by TYRA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of TYRA in WallStreetBets Daily Discussion


Recent insights relating to TYRA

CNBC Recommendations

Recent picks made for TYRA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TYRA

Corporate Flights

Flights by private jets registered to TYRA